Description
Latin name
Licopid
Release form
Tablets.
packaging 10 pcs
Indications
The drug is used in adults and children (from 3 years) in the complex treatment of diseases, accompanied by secondary immunodeficiency states:
Children: chronic
, recurrent upper and lower respiratory infections in the acute stage and in remission
acute and chronic purulent-inflammatory diseases of the skin and soft tissues (pyoderma, furunculosis and others)
.
Adults:
chronic respiratory infections
acute and chronic purulent-inflammatory diseases of the skin and soft tissues (pyoderma, furunculosis and others)
herpetic infection.
Prophylactic administration (adults):
prophylaxis and reduction of seasonal incidence of acute respiratory infections and the frequency of exacerbations of chronic diseases of ENT organs, upper and lower respiratory tract.
Contraindications
hypersensitivity to glucosaminylmuramyl dipeptide and other components of the drug
pregnancy and lactation
children under 18 years of age
autoimmune thyroiditis in the acute phase of
congenital metabolic disorders: alactasia, galactosemia, lactase deficiency, lactose intolerance, sucrose / isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption
use in autoimmune diseases is not recommended due to lack of clinical data.
Use during pregnancy and lactation
Taking Likopid ® 1 mg is contraindicated in women during pregnancy and breastfeeding.
Composition
Active ingredient: glucosaminylmuramyl dipeptide (GMDP) – 1.0 mg. Excipients: lactose monohydrate – 73.88 mg, sugar (sucrose) – 5.0 mg, potato starch – 19.0 mg, methyl cellulose – 0.12 mg, calcium stearate – 1.0 mg.
Dosage and administration
Lycopid ® is administered orally or sublingually on an empty stomach, 30 minutes before meals.
If you missed the drug, if no more than 12 hours have passed from the planned time, you can take the missed dose if more than 12 hours have passed from the planned time, you need to take only the next dose according to the scheme and not take the missed one.
Dose adjustment in certain groups of patients (elderly people, patients with impaired liver function, patients with impaired renal function) is not required.
Children:
Acute and chronic suppurative inflammatory diseases of the skin and soft tissues (pyoderma, furunculosis and others): 1 tablet 1 time per day under the tongue for 10 days.
Chronic, recurrent infections of the upper and lower respiratory tract (in the acute stage and in remission): Likopid ® is taken in 3 courses, 1 tablet 1 time per day under the tongue for 10 days, with a break between courses of 20 days.
Herpetic infection: 1 tablet 3 times a day inside or under the tongue for 10 days.
Adults:
Chronic respiratory infections: 2 tablets 1 time per day under the tongue for 10 days.
Acute and chronic purulent-inflammatory diseases of the skin and soft tissues (pyoderma, furunculosis and others): 2 tablets 2-3 times a day under the tongue for 10 days.
Herpetic infection: 2 tablets 3 times a day, inside or under the tongue for 10 days.
Prevention (adults):
to prevent or reduce the seasonal incidence of acute respiratory infections and the frequency of exacerbations of diseases of ENT organs, upper and lower respiratory tract Likopid ® take 1 tablet 3 times a day under the tongue for 10 days.
Side effects
Often (1-10%) – at the beginning of treatment, there may be a short-term increase in body temperature to subfebrile values (up to 37.9 ° C), which is not an indication for drug withdrawal.
Rarely (0.01-0.1%) – short-term increase in body temperature to febrile values (> 38.0 ° C). With an increase in body temperature above 38.0 ° C, antipyretic drugs are possible, which does not reduce the pharmacological effects of Likopid ® tablets.
Very rarely (less than 0.01%) – diarrhea.
If any of the side effects indicated in the instructions are aggravated, or you notice any other side effects not listed in the instructions, inform your doctor.
overdose
Drug overdose is unknown.
Based on the pharmacological properties of the drug, in the event of its overdose, a rise in body temperature to subfebrile (up to 37.9 ° C) values may be observed. If necessary, symptomatic therapy (antipyretics) is performed, sorbents are prescribed. The specific antidote is unknown.
Storage conditions
List B. The drug should be stored in a dry, protected from light, out of reach of children at a temperature not exceeding 25 ° C.
Expiration
5 years.
Do not use after the expiry date.
Deystvuyuschee substances
Hlyukozamynylmuramyldypeptyd
Dosage form
dosage form
tablets
Peptek ZAO, Russia
